Bortezomib will increase the degree or influence of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. Increased flibanserin adverse outcomes might come about if coadministered with numerous weak CYP3A4 inhibitors. elvitegravir/cobicistat/emtricitabine/tenofovir DF raises amounts of bortezomib by impacting hepatic/intestinal enzyme CYP3A4 metaboli... https://win-55-212-2-mesylate88654.pages10.com/the-smart-trick-of-verteporfin-that-nobody-is-discussing-62495460